There have been several reports of decreased inhibition of
calcium oxalate crystal growth (11-14) and of calcium oxalate
crystal growth and aggregation (1) in urine from patients with
urolithiasis as compared with normal subjects. In evaluating
and treating patients with calcium oxalate stone disease, it